The global Friedreich’s ataxia market is experiencing notable growth, fueled by advancements in genetic research, enhanced diagnostic technologies, and increased awareness of this rare ...

Since July, several biotechs have been forced to pivot as previous agreements with the FDA around evidence required for approval were reversed, a phenomenon that, according to experts, could portend a ...

The FDA has issued an emergency use authorization for lotilaner chewable tablets (Credelio CAT; Elanco Animal Health) for treating New World screwworm (NWS) infestations in cats and kittens. Credelio ...

MUM Nicky Starkowitz felt like she’d been “hit by a train” when her son Raffi was handed his cancer diagnosis. The only clue ...

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...

A fast-spreading horse virus is forcing West Texas owners, arenas and officials to tighten precautions to prevent a ...

On Nov. 4, a 5-year-old Appaloosa mare in Kiowa County, Oklahoma, tested positive for West Nile virus (WNV). The unvaccinated horse developed clinical signs on Oct. 20, including ataxia, loss of ...

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...

Biohaven (EXCHANGE:BHVN) Chief Executive Officer Vlad Coric acquired 666,666 common shares in two transactions on November 13, 2025, at a price of $7.50 per share, for a total value of $4,999,995. The ...

The purchase was made by John W Childs 2013 Revocable Trust. Following the transaction, the trust holds 5,653,904 common shares of Biohaven Ltd.

Today, Benzinga's options scanner spotted 8 options trades for Biogen. This is not a typical pattern. The sentiment among ...

The Oxford-Harrington Rare Disease Centre ('OHC') today announced the recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice.